Home > Financial Ratios > VALIANT LABORATORIES

VALIANT LABORATORIES
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

VALIANT LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023
   Core EBITDA Growth(%) -40.72-96.81-

What is the latest Core EBITDA Growth ratio of VALIANT LABORATORIES ?

The latest Core EBITDA Growth ratio of VALIANT LABORATORIES is -40.72 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-40.72
Mar2024-96.81
Mar2023-

How is Core EBITDA Growth of VALIANT LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 -40.72
Negative
Mar2024 -96.81
0
Mar2023 0 -

Other Financial Ratios of VALIANT LABORATORIES


Compare Core EBITDA Growth ratio of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹314.9 Cr -2.5% -17.7% -40.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,828.0 Cr -1.8% -6.4% -10.7% Stock Analytics
DIVIS LABORATORIES ₹158,227.0 Cr -0.3% -5.5% 8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,045.0 Cr -0.1% 4% 18.7% Stock Analytics
CIPLA ₹105,961.0 Cr 1% -12.3% -5.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,682.5 Cr -4.6% -7% 1.8% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

-2.5%

-17.7%

-40.7%

SENSEX

-0.2%

-4.2%

8.4%


You may also like the below Video Courses